Cure My Disease

Don't miss your cure!

 Log in / Sign up

Microbeads aim to zap plantar fasciitis pain

NCT ID NCT07241884

Symptom relief Sponsor: CrannMed Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new treatment for heel pain caused by plantar fasciitis. Tiny, dissolvable beads are injected to block blood flow to the painful area. The goal is to see if this procedure safely reduces pain better than standard care. About 45 adults with chronic heel pain will take part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 45 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patient is able and willing to provide written informed consent, and 2. Age 18 to 75 years (inclusive), and 3. Clinical diagnosis of PF with proximal plantar fascia thickness greater than 4mm and areas of hypoechogenicity. Exclusion Criteria: 1. Acute internal derangement of the foot including acute meniscal, ligament or bone injury, or 2. Sensory or motor neuropathy of the feet, or 3. Heel pain caused by stress fractures, nerve entrapment, or inflammatory conditions such as arthritis, gout, or bursitis, or 4. Prior surgical repair or plantar fascia rupture in the involved foot, or 5. Local infection in either foot, or 6. Contraindication to MRI, or 7. Active pregnancy as demonstrated by urine or serum β-hCG or lactating female 8. Unable to provide informed consent or comply with the conditions of the study, or 9. At the discretion of the Principal Investigator

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Heel pain are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

fasciitis Foot Diseases musculoskeletal system disorder plantar fasciitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Heel pain Musculoskeletal diseases Plantar fascitis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Nano Medical Clinic

    RECRUITING

    Tashkent, Uzbekistan, 100095, Uzbekistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.